To compare between kantak panchamoola vasti and standard treatment in the treating diabetes mellitus type II (Prameha)

Evaluation of comparative efficacy of kantak panchamoola vasti followed by KP vati versus standard treatment in the management of diabetes mellitus type II (Prameha) - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071096

Enrollment

Registered

2024-07-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to give written informed consent Patient with either sex having age between 20 to 60 years Patients recently diagnosed for uncomplicated NIDDM less than 6months and having Fasting blood sugar level 126 to 200 mg per dl and Post meal blood sugar level 140 to 300mg per dl Patients with type 2 DM for 6 months but not taking any other anti-hypoglycemic drug Diabetic Patients suffering from controlled hypertension that is Systolic blood pressure not more 140mmHg or an average Diastolic Blood Pressure not more 90mmHg Patient fit for Vasti Karma as per the Ayurvedic classics Newly Diagnosed Diabetic patients who are not willing for Allopathic medication

Exclusion criteria

Exclusion criteria: Patients suffering from Insulin dependent diabetes mellitus and patient with Type 2 Diabetes patient on insulin therapy Patients suffering from Juvenile Diabetes or Gestational diabetes Impaired glucose tolerance DM with complications example Retinopathy Nephropathy neuropathy previous history of coma Patients suffering from any current acute illness uncontrolled hypertension Pregnant and Lactating woman

Design outcomes

Primary

Measure	Time frame
To assess and compare the efficacy of Kantak Panchamoola Vasti followed by KP Vati and Tab Metformin over Blood sugar levels Fasting and Post prandial Urine Sugar and HbA1C level in Diabetes Mellitus Type IITimepoint: at baseline 16 days 48 days	—

Secondary

Measure	Time frame
Comparison and Assessment of efficacy of Kantak Panchamoola Vasti followed by KP Vati and Tab Metformin over Blood sugar levels Fasting and Post prandial Urine Sugar and HbA1C levelTimepoint: 2 Week 2 days	—

Countries

India

Contacts

Public ContactDr Punam Sawarkar

Mahatma Gandhi Ayurved College Hospital and Research Center

asrekhe@gmail.com9860862405

Outcome results